Elizabeth Holmes, the convicted founder of the defunct blood-testing startup Theranos, has been denied her bid for a new trial, The Wall Street Journal reported Nov. 8.
Ms. Holmes was convicted in January of four counts of defrauding investors in a yearslong scheme at the company that claimed to be able to do comprehensive tests with a tiny amount of blood. She faces up to 20 years in prison on each count at her Nov. 18 sentencing.
She requested a new trial in September, saying a witness had recanted his testimony. But that witness denied those claims.
U.S. District Judge Edward Davila ruled Nov. 7 that Ms. Holmes didn't produce material new evidence or prove government misconduct and that a new trial was unlikely to lead to an acquittal, the Journal reported.
Her attorneys didn't respond to a request from the news outlet for comment. The news was first reported Nov. 7 by Reuters.